Procter & Gamble Health Limited
NSE:PGHL.NS
5,158.45 (INR) • At close September 16, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Procter & Gamble Health Limited |
Symbool | PGHL.NS |
Munteenheid | INR |
Prijs | 5,158.45 |
Beurswaarde | 85,627,174,930 |
Dividendpercentage | 5.25% |
52-weken bereik | 4,636.55 - 5,642.85 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Milind Vasant Thatte M.B.A. |
Website | https://www.pghealthindia.com |
An error occurred while fetching data.
Over Procter & Gamble Health Limited
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)